Medicare utilization — RAMBABU TUMMALA (MD)
Calendar year 2023 · data refreshed 2026-05-27
| HCPCS | Description | Services | Beneficiaries | Allowed | Payment |
|---|---|---|---|---|---|
| Q0138 | Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use) | 37,740 | 35 | $0 | $14,813 |
| J9271 | Injection, pembrolizumab, 1 mg | 23,400 | 12 | $0 | $1,011,064 |
| J0897 | Injection, denosumab, 1 mg | 14,580 | 71 | $0 | $268,743 |
| J0185 | Injection, aprepitant, 1 mg | 10,790 | 18 | $0 | $13,165 |
| J0885 | Injection, epoetin alfa, (for non-esrd use), 1000 units | 10,060 | 32 | $0 | $59,229 |
Service volume and Medicare payment amounts do not indicate quality of care, patient outcomes, or fraud. Data reflects Medicare fee-for-service only.
Source: CMS public data · Not endorsed by CMS · Beneficiary counts under 11 are suppressed in source data ·